Learn about the latest developments in cardiovascular disease prevention through a comprehensive cardiology rounds lecture delivered by Dr. Ruth McPherson, a distinguished expert holding the Merck Frosst Canada Chair in Atherosclerosis Research. Explore both established and emerging therapies for dyslipidemia, covering crucial topics including LPA, primary prevention strategies, and the relationship between HDL and LDL cholesterol. Gain insights into CCS guidelines, atherosclerosis management, and various treatment approaches including statins, PCSK9 inhibitors, and intravascular ultrasound techniques. Examine the latest research on hypertriglyceridemia, EPA vs DHA effectiveness, and the role of anti-inflammatory treatments such as colchicine and methotrexate in cardiovascular care. Understand current Canadian treatment protocols and practical implementation strategies for managing lipid disorders in clinical practice.
Dyslipidemia - New and Old Therapies for Cardiovascular Disease Prevention
University of Ottawa Heart Institute via YouTube
Overview
Syllabus
Introduction
LPA
Primary prevention
HDL vs LDL
CCS guidelines
Atherosclerosis
Guidelines
Lowering LDL
Inhibitors
Statins
PCSK9 inhibitors
Intravascular Ultrasound
Sirna
Orion Knife
Overall results
Safety data
Cardiovascular outcome data
Where do we stand in Canada
How do you do this
LDL
Hyper Triglyceridemia
Guidelines Recommendations
Study Results
EPA vs DHA
Culture
Colchicine
Antiinflammatory
Methotrexate
Solidoko
Lowdose Colchicine
In Circulation
Taught by
University of Ottawa Heart Institute
